News | April 07, 2024
LANXESS showcases extensive portfolio for the cosmetics industry at in-cosmetics Global
Highly effective preservation solutions ensuring the safety and protection of personal care products
Highly effective preservation solutions ensuring the safety and protection of personal care products
Enhertu now has five approved indications with the latest in HER2-expressing (IHC 3+) metastatic cancers
International Business is expected to register double-digit growth in constant currency terms
TriClip offers a remarkably safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery
Reconfirms a relative bioavailability of 65 percent and significant savings when using DL-methionine
These facilities are commissioned by Aurobindo's wholly own subsidiary: Lyfius Pharma Private Limited, Qule Pharma Private Limited, Eugia Steriles Private Limited and Auroactive Pharma Private Limited.
First and only AKT inhibitor approved in Japan for breast cancer patients with specific biomarker alterations
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
Subscribe To Our Newsletter & Stay Updated
